Call for Presenters: We are pleased to announce our call for emerging companies and innovators that would like to present in the Emerging Company and Innovators Showcase at the Life Sciences Summit 2010. The Emerging Company & Innovator’s Showcase will feature 15-minute presentations by 40 early stage companies with close ties to an academic institution and academic innovators seeking collaboration with a biopharmaceutical company.

Areas of Focus: The areas of focus for the 2010 Life Science Summit are infectious disease, neurology, oncology and regenerative medicine.

To Request a Presentation Slot: If your organization incubates companies that you think would be interested in this opportunity, please forward this email to them or click here (http://www.lifesciencessummit.org/2010/) to request a slot.

Who Should Present: Emerging companies (A Round or pre-A Round) with close ties to academic institutions and academic researchers/innovators are invited to present at the Biotech Showcase. The Life Sciences Summit is a translational science partnering meeting. We are looking for presenters that are inte rested in collaborating with industry in order to advance their science in the therapeutic development process. The areas of focus this year are infectious disease, neurology, oncology, regenerative medicine. Presenters will not be limited to these four broad areas.

Why Should You Present: You should present if you want to gain exposure to potential collaborators and/or investors.

What is Partnering: Partnering is a formal process utilized extensively in the biopharmaceutical industry that allows meeting attendees to identify potential collaborators, request meetings with them, and organize meetings on site during the course of an event. All Life Sciences Summit attendees will be enrolled in Collaborate(TM), the Life Sciences Summit online partnering program.

About the Life Sciences Summit

The Life Sciences Summit 2010 is a partnering meeting that attracts leading biopharmaceutical industry representatives and early stage investors seeking new business opportunities, next generation product candidates, and investment opportunities.

The Life Sciences Summit is for academic researchers and faculty who are interested in collaborating with industry, emerging companies interested in licensing and partnerships, and biopharmaceutical companies interested in learning working with academic innovators and emerging companies.

For more information, visit our website: www.lifesciencessummit.org

Contact I nformation:

For presenters:

- Joe Scaduto: jscaduto@stonybrook.edu or +1 (631) 632-1064
- Michael Bielski: mbielski@stonybrook.edu or +1 (631)632-8443

For more information about the conference:

- Diane Fabel: dfabel@lifesciencessummit.org or +1 (631) 632-1582
- Sara Jane Demy: sdemy@lifesciencessummit.org or +1 (212) 288-4233

Webinar 

Understanding the Medical Device Market and  Regulatory Framework in China

May 31, 2010, 20:00-21:30 Ottawa Time

Canadian companies that have experience working with regional health authorities in Canada or on the Canadian Health Infoway (CHI) networked projects are well placed to bring their interoperable solutions to the U.S. market.  Did you know that the healthcare industry is receiving $142.3 billion from the U.S. stimulus package? This represents more than any other sector.

• Discover regional opportunities directly from trade commissioners in Philadelphia and New York.
• Gain insight on privacy, security, sustainability and interoperability related to the U.S. Health IT industry – What lessons have we learned?
• Learn how wireless technology is revolutionizing the delivery of health services.

]]> http://ls.ocri2.com/?feed=rss2&p=464 0 http://ls.ocri2.com/?p=449 http://ls.ocri2.com/?p=449#comments Thu, 12 Nov 2009 17:48:36 +0000 azielinski http://ls.ocri2.com/?p=449 The University of Ottawa Telfer School of Management

is pleased to invite you to the next BioTech themed breakfast.

 James Pelot

 Chief Financial Officer, ArcticDX

Discussing:

“From Bench to Box – a genetic testing biotech start-up journey”

Date:              Wednesday, November 25, 2009

Time:             7:00 a.m.                     Coffee and networking

7:30 a.m.                     Breakfast

8:00 a.m. – 9:00 a.m.   Presentation

Location:       Telfer School of Management

                       Desmarais Building, Room 4101, 4^th Floor

55 Laurier E., Ottawa ON, K1N 6N5

                       (“Pay and Display” parking available under Desmarais Building)

                       OC Transpo: Laurier Station

Price:             $30 per person

$20 for uOttawa students and alumni

RSVP:            Before November 23, 2009 – Register early. Seats are limited.

(Payable in advance by MasterCard, Visa, cash or cheque.)

No-shows will be billed.  Substitutions are allowed at any time.

Register online:        

http://www.alumboutique.ca/  (Click English, Events, Ottawa Area Events)

Contact us:                Tel.: (613) 562-5800 x 2396  

Fax: (613) 562-5332

alumni@telfer.uOttawa.ca

Biography

Mr. James Pelot

Chief Financial Officer,

ArcticDX

Mr. Pelot was Chief Financial Officer and Chief Operating Officer of Tm Bioscience Corporation until March of 2007. Tm Bioscience (now Luminex Molecular Diagnostics) is a leader in the field of development, manufacturing and commercialization of genetic tests. From his appointment in September 2001, Mr. Pelot was responsible for the development of the Company’s infrastructure, securing capital, investor relations and financial reporting. Mr. Pelot’s key accomplishments include raising in excess of $75 million in funds from public, private and governmental sources; graduating the Company to the TSX from the TSX – Venture stock exchange and registering the Company as a reporting issuer in the U.S. Prior to joining Tm Bioscience, Mr. Pelot was a co-founder of a wireless internet company acquired by InfoSpace and served in various executive roles within sales, marketing and finance both there and at Nortel Networks Limited. Mr. Pelot holds a B. Commerce degree from the University of Ottawa and is a Chartered Accountant.

Event partners: CATA, Ottawa Business Journal, uOttawa Faculty of Science

At the International Swine Flu Conference, attendees will be able to draw on first-hand best practices to create the solid business continuity plans that their companies and organizations need in order to prepare for, respond to, and survive a pandemic.

The International Swine Flu Conference draws on the success of the seven previous Bird Flu summits which featured as speakers several distinguished personalities such as Dr. David Nabarro, the United Nations Coordinator for Avian and Human Influenza, Alex Thiermann of the World Organization for Animal Health (OIE) and Dr. Wenqing Zhang of the WHO Epidemic and Pandemic Alert and Response.

For more information or to register visit http://new-fields.com/isfc_canada/

PLEASE NOTE: Life Science and cleantech companies are eligible for all award categories. The Health Innovation and Research awards have been carried over from the Life Sciences Awards. We encourage all life science and cleantech companies to browse the available award categories and submitt a nomination.

RECOGNITION • EXPOSURE • OPPORTUNITY

The OCRI Awards are synonymous with business excellence in the Ottawa region, shining a spotlight on the people and innovation that set the standard and serve as role models in our region. With three new awards, the 2010 OCRI Awards will recognize the most innovative individuals, teams and organizations who have contributed to Ottawa’s knowledge-based community by way of research, technology, entrepreneurship, leadership, partnerships and student accomplishment. The OCRI Awards dinner is the largest and most inclusive knowledge-based industry event in Ottawa, involving all sizes and sectors of Ottawa’s knowledge-based companies.

Those who participate in the OCRI Awards benefit through:

• Recognition as a leading knowledge-based company or individual who demonstrates extraordinary excellence. Set yourself apart from the competition and become a 2010 OCRI Award Finalist or Winner!
• Exposure via media distribution channels and the marketing and communications program delivered by OCRI to showcase all the finalists and winners.
• Opportunity to capture the eye of many industry observers as a recognized OCRI Award finalist. Investors look for quality assurance and quality knowledge-based talent dream of working for companies that inspire innovation. Give them the reason they need to keep your company at the forefront of consideration.

Three finalists will be chosen from each category. The winner will be announced at the Awards Dinner on April 8, 2010 at the Hilton Lac-Leamy.

For more information please visit http://www.ocri.ca/awards/

BiOS is the world’s largest and most prestigious international biomedical optics and imaging conference, encompassing clinical, translational, and fundamental R&D.  BiOS provides you with a premier technical forum for reporting your achievements and learning about the latest clinical and technical advances. BiOS is a major impetus for launching new applications and technologies; patent citations indicate the importance of the research introduced in these conferences.

http://www.ottawaregion.com/_news/news_1464.php

http://www.medec.org/events_and_programs

Xiaoyi Bao, a professor in the Department of Physics at the Faculty of Science, holds the Canada Research Chair in Fibre Optics and Photonics. Her research interests include high-speed transmission systems using fibre optics. Bao and her team are working to develop a sensor that can measure the temperature and soundness of large structures like buildings, duct systems and oil wells in order to detect any wear in the structure’s fibre optics.

Annie Brisset is a professor at the School of Translation and Interpretation and the Department of Theatre. She is also a consultant to UNESCO on the development of multilingual communication and is a founding member of the International Association for Translation and Intercultural Studies (IATIS). Her areas of interest include sociology and sociocritique of translation, translation theories and discourse theories.

http://www.media.uottawa.ca/mediaroom/news-details_1737.html

Canada’s bio-based economy is valued at 78.3 billion dollars. At 6.4 percent of the GDP, this footprint is larger than the automotive and aerospace sectors respectively.

The concept of the bio-based economy goes beyond the traditional definition of biotechnology. The bio-based economy focuses on biological tools and products from renewable resources to create wealth and sustainability in the production of medical treatments, diagnostics, more-nutritional foods, energy, chemicals, and materials, while improving the quality of the environment.

Visit www.beyondmooseandmountains.ca to learn more and take part in the campaign.